Trump's proposed 200% tariff is a wake-up call, but India's bigger pharma risk lies in China, say experts

From the publisher

Announcing the policy, Trump said the move was intended to encourage companies to manufacture generic medicines domestically. What impact will Trump's proposed 200% tariff on generic drugs have on India's pharmaceutical industry?

The source's own excerpt, unedited